T1	Outcomes 202 224	local tumor recurrence
T2	Outcomes 827 862	pathological complete response (pCR
T3	Outcomes 913 937	safety and efficacy. TMN
T4	Outcomes 1069 1098	grade 1/2 acneiform skin rash
T5	Outcomes 1110 1134	grade 3 radiodermatitis,
T6	Outcomes 1142 1150	diarrhea
T7	Outcomes 1161 1177	hypersensitivity
T8	Outcomes 1184 1187	pCR
T9	Outcomes 1231 1257	T- and N-downstaging rates
T10	Outcomes 1294 1327	Total sphincter preservation rate
T11	Outcomes 1419 1456	Non-fatal perioperative complications
T12	Outcomes 1492 1513	delayed wound healing
T13	Outcomes 1776 1800	pathological downstaging